![]() Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers. | ![]() Inhibitor Therapeutics Inhibitor Therapeutics (formerly known as HedgePath Pharmaceuticals) is a pharmaceutical company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders. | Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. | OnQuality Pharmaceuticals OnQuality Pharmaceuticals is a pharmaceutical company specialized in the development and commercialization of drugs and drug delivery systems in the area of oncology. | ||
Founding Date | Founding Date 2017 | Founding Date 2011 | Founding Date 1992 | Founding Date N/A | Founding Date 2019 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations New York, US HQ | Locations Cambridge, US HQ | Locations Tampa, US HQ | Locations New Haven, US HQ | Locations HQ |
Employees | Employees 3 | Employees 22 | Employees 233% decrease | Employees 13329% increase | Employees 7 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 47.5 m | Valuation ($) 12.9 m | Valuation ($) 1.9 b | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($35.2m) (FY, 2023) | Net income ($3m) (FY, 2023) | Net income ($367.3m) (FY, 2023) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 43m | Total funding raised $ 150.3m | Total funding raised N/A | Total funding raised $ 111.6m | Total funding raised N/A |
Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.
View companyInhibitor Therapeutics (formerly known as HedgePath Pharmaceuticals) is a pharmaceutical company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders.
View companyArvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
View companyOnQuality Pharmaceuticals is a pharmaceutical company specialized in the development and commercialization of drugs and drug delivery systems in the area of oncology.
View company